Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TEVA - Teva Won't Find Relevancy Through Cannabis


TEVA - Teva Won't Find Relevancy Through Cannabis

Daniel Goldmeier of Goldmeier Investments assisted in writing this article.

Too Much Risk Too Soon

Israel's Teva Pharmaceutical Industries Ltd. (TEVA) share price sells a notch above its 19 years low. Yet, I do not recommend retail investors buy this stock now. The company has no major catalysts on the horizon. TEVA still has significant though more manageable debt. It remains exposed to legal liabilities related to the opioid crisis and U.S. charges of price-fixing of pharmaceuticals. In my opinion, given the high risk and low reward profile, retail investors have no business

Read more ...

Stock Information

Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com

Menu

TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...